Suivre
Douglas Kazutoshi Sato
Titre
Citée par
Citée par
Année
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders
DK Sato, D Callegaro, MA Lana-Peixoto, PJ Waters, FM de Haidar Jorge, ...
Neurology 82 (6), 474-481, 2014
7852014
MRI characteristics of neuromyelitis optica spectrum disorder: an international update
HJ Kim, F Paul, MA Lana-Peixoto, S Tenembaum, N Asgari, J Palace, ...
Neurology 84 (11), 1165-1173, 2015
5342015
MOG cell-based assay detects non-MS patients with inflammatory neurologic disease
P Waters, M Woodhall, KC O'Connor, M Reindl, B Lang, DK Sato, ...
Neurology-Neuroimmunology Neuroinflammation 2 (3), 2015
3242015
MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy
R Ogawa, I Nakashima, T Takahashi, K Kaneko, T Akaishi, Y Takai, ...
Neurology-Neuroimmunology Neuroinflammation 4 (2), 2017
3062017
Neuromyelitis optica and multiple sclerosis: seeing differences through optical coherence tomography
JL Bennett, J De Seze, M Lana-Peixoto, J Palace, A Waldman, ...
Multiple Sclerosis Journal 21 (6), 678-688, 2015
2692015
Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders
A Jacob, A McKeon, I Nakashima, DK Sato, L Elsone, K Fujihara, ...
Journal of Neurology, Neurosurgery & Psychiatry 84 (8), 922-930, 2013
2152013
Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients
MI Leite, E Coutinho, M Lana-Peixoto, S Apostolos, P Waters, D Sato, ...
Neurology 78 (20), 1601-1607, 2012
2052012
Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients
MI Leite, E Coutinho, M Lana-Peixoto, S Apostolos, P Waters, D Sato, ...
Neurology 78 (20), 1601-1607, 2012
2052012
MOG-IgG-associated optic neuritis, encephalitis, and myelitis: lessons learned from neuromyelitis optica spectrum disorder
GR Dos Passos, LM Oliveira, BK Da Costa, SL Apostolos-Pereira, ...
Frontiers in neurology 9, 217, 2018
1792018
Th17 cells pathways in multiple sclerosis and neuromyelitis optica spectrum disorders: pathophysiological and therapeutic implications
GRD Passos, DK Sato, J Becker, K Fujihara
Mediators of inflammation 2016, 2016
1462016
Myelin-oligodendrocyte glycoprotein antibody-associated disease
R Marignier, Y Hacohen, A Cobo-Calvo, AK Pröbstel, O Aktas, ...
The Lancet Neurology 20 (9), 762-772, 2021
1402021
MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study
T Akaishi, DK Sato, I Nakashima, T Takeshita, T Takahashi, H Doi, ...
Journal of Neurology, Neurosurgery & Psychiatry 87 (4), 446-448, 2016
1352016
Aquaporin-4 antibody–positive cases beyond current diagnostic criteria for NMO spectrum disorders
DK Sato, I Nakashima, T Takahashi, T Misu, P Waters, H Kuroda, ...
Neurology 80 (24), 2210-2216, 2013
1202013
Update on biomarkers in neuromyelitis optica
E Melamed, M Levy, PJ Waters, DK Sato, JL Bennett, GR John, ...
Neurology-Neuroimmunology Neuroinflammation 2 (4), 2015
1152015
Bilateral frontal cortex encephalitis and paraparesis in a patient with anti-MOG antibodies
J Fujimori, Y Takai, I Nakashima, DK Sato, T Takahashi, K Kaneko, ...
Journal of Neurology, Neurosurgery & Psychiatry 88 (6), 534-536, 2017
1112017
CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications
K Kaneko, DK Sato, I Nakashima, R Ogawa, T Akaishi, Y Takai, ...
Journal of Neurology, Neurosurgery & Psychiatry 89 (9), 927-936, 2018
1022018
Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies
K Kaneko, DK Sato, I Nakashima, S Nishiyama, S Tanaka, R Marignier, ...
Journal of Neurology, Neurosurgery & Psychiatry 87 (11), 1257-1259, 2016
892016
Treatment of MOG-IgG-associated disorder with rituximab: an international study of 121 patients
DH Whittam, A Cobo-Calvo, AS Lopez-Chiriboga, S Pardo, M Gornall, ...
Multiple sclerosis and related disorders 44, 102251, 2020
882020
Neuromyelitis optica should be classified as an astrocytopathic disease rather than a demyelinating disease
K Fujihara, T Misu, I Nakashima, T Takahashi, M Bradl, H Lassmann, ...
Clinical and Experimental Neuroimmunology 3 (2), 58-73, 2012
882012
Treatment of neuromyelitis optica: an evidence based review
D Sato, D Callegaro, MA Lana-Peixoto, K Fujihara
Arquivos de neuro-psiquiatria 70, 59-66, 2012
812012
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20